Notification
No new Notification messages
Pranik Logistics IPO is Open!
Apply for the Pranik Logistics IPO through UPI in just minutes.
Latest: Network18 Q2 Results FY'25
Network18 group the parent brand of JioCinema and Moneycontrol announced its Q2 results for FY'25.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
Trade Now, Pay Later with up to 4x Leverage
Never miss a good trading opportunity due to low funds with our MTF feature.
NSE BSE
auro laboratories ltd. stock

AURO LABORATORIES LTD. Share Price

219.65 4.79 (2.22%)
Oct 14 2024 03:29 PM Pharmaceuticals NSE: AUROLAB

AURO LABORATORIES LTD. Share Price Update

As of the latest trading session, AURO LABORATORIES LTD. share price is currently at 219.65, which is up by 4.79 from its previous closing. Today, the stock has fluctuated between 215.00 and 227.00. Over the past year, AURO LABORATORIES LTD. has achieved a return of 79.41 %. In the last month alone, the return has been 12.78 %. Read More...

AURO LABORATORIES LTD. Performance

Day Range

Low215.00 High227.00
219.65

52 Week Range

Low 105.20 High 307.20
219.65

AURO LABORATORIES LTD. Share Price

530233

AUROLAB

img img img img
No Data Available

Open Price

227.00

Prev. Close

214.85

Volume (Shares)

12620.00

Total traded value

27.71

Upper Circuit

237.75

Lower Circuit

194.55

Note: The current prices & values are delayed, Login to your account for live updates.

AURO LABORATORIES LTD. Fundamentals


(Standalone)

Market Cap (Cr) 136.80
PE Ratio (TTM) 17.22
Book Value / Share 67.34
Beta 0.38
ROE 20.46%
EPS (TTM) 12.48
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.75

AURO LABORATORIES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 5.72
Operating Expense 4.92
Net Profit 0.75
Net Profit Margin (%) 13.11
Earnings Per Share (EPS) 1.21
EBITDA 1.53
Effective Tax Rate (%) 24.75
Particulars MAR 2024 (Values in Cr)
Revenue 12.06
Operating Expense 9.62
Net Profit 2.32
Net Profit Margin (%) 19.23
Earnings Per Share (EPS) 3.72
EBITDA 2.81
Effective Tax Rate (%) 18.59
Particulars DEC 2023 (Values in Cr)
Revenue 17.98
Operating Expense 14.61
Net Profit 2.73
Net Profit Margin (%) 15.18
Earnings Per Share (EPS) 4.39
EBITDA 4.50
Effective Tax Rate (%) 27.70
Particulars SEP 2023 (Values in Cr)
Revenue 13.41
Operating Expense 11.00
Net Profit 1.97
Net Profit Margin (%) 14.69
Earnings Per Share (EPS) 3.16
EBITDA 3.35
Effective Tax Rate (%) 27.83
Particulars JUN 2023 (Values in Cr)
Revenue 10.18
Operating Expense 9.57
Net Profit 0.71
Net Profit Margin (%) 6.97
Earnings Per Share (EPS) 1.14
EBITDA 1.52
Effective Tax Rate (%) 27.55
Particulars MAR 2024 (Values in Cr)
Revenue 53.64
Operating Expense 44.80
Net Profit 7.79
Net Profit Margin (%) 14.52
Earnings Per Share (EPS) 12.50
EBITDA 12.18
Effective Tax Rate (%) 24.63
Particulars MAR 2023 (Values in Cr)
Revenue 52.89
Operating Expense 50.39
Net Profit 2.44
Net Profit Margin (%) 4.61
Earnings Per Share (EPS) 3.92
EBITDA 5.33
Effective Tax Rate (%) 28.98
Particulars MAR 2022 (Values in Cr)
Revenue 50.87
Operating Expense 48.08
Net Profit 2.84
Net Profit Margin (%) 5.58
Earnings Per Share (EPS) 4.56
EBITDA 5.72
Effective Tax Rate (%) 26.61
Particulars MAR 2021 (Values in Cr)
Revenue 54.25
Operating Expense 44.51
Net Profit 7.18
Net Profit Margin (%) 13.23
Earnings Per Share (EPS) 11.52
EBITDA 12.01
Effective Tax Rate (%) 31.68
Particulars MAR 2020 (Values in Cr)
Revenue 43.79
Operating Expense 39.12
Net Profit 4.05
Net Profit Margin (%) 9.24
Earnings Per Share (EPS) 6.51
EBITDA 7.24
Effective Tax Rate (%) 28.19
Particulars MAR 2024 (Values in Cr)
Book Value / Share 67.32
ROE % 20.46
ROCE % 20.37
Total Debt to Total Equity 0.43
EBITDA Margin 22.71
Particulars MAR 2023 (Values in Cr)
Book Value / Share 54.87
ROE % 7.43
ROCE % 9.89
Total Debt to Total Equity 0.31
EBITDA Margin 10.08
Particulars MAR 2022 (Values in Cr)
Book Value / Share 50.58
ROE % 9.45
ROCE % 12.20
Total Debt to Total Equity 0.28
EBITDA Margin 11.24
Particulars MAR 2021 (Values in Cr)
Book Value / Share 45.86
ROE % 28.67
ROCE % 38.90
Total Debt to Total Equity 0.13
EBITDA Margin 22.12
Particulars MAR 2020 (Values in Cr)
Book Value / Share 34.49
ROE % 20.82
ROCE % 24.80
Total Debt to Total Equity 0.29
EBITDA Margin 16.56
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.41
Total Assets 55.99
Total Liabilities 55.99
Total Equity 34.20
Share Outstanding 6232500
Price to Book Ratio 1.00
Return on Assets (%) 4.36
Return on Capital (%) 6.01
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 12.39
Total Assets 54.96
Total Liabilities 54.96
Total Equity 31.52
Share Outstanding 6232500
Price to Book Ratio 1.98
Return on Assets (%) 5.17
Return on Capital (%) 6.28
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 14.53
Total Assets 41.89
Total Liabilities 41.89
Total Equity 28.58
Share Outstanding 6232500
Price to Book Ratio 1.77
Return on Assets (%) 17.13
Return on Capital (%) 22.7
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 5.68
Total Assets 32.34
Total Liabilities 32.34
Total Equity 21.49
Share Outstanding 6232500
Price to Book Ratio 0.91
Return on Assets (%) 12.53
Return on Capital (%) 16.45
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 4.10
Total Assets 33.46
Total Liabilities 33.46
Total Equity 17.41
Share Outstanding 6232500
Price to Book Ratio 2.13
Return on Assets (%) 13.14
Return on Capital (%) 17.25
Particulars MAR 2024 (Values in Cr)
Net Income 10.34
Cash from Operations 18.80
Cash from Investing -38.67
Cash from Financing 19.09
Net change in Cash -0.76
Free Cash Flow 54.44
Particulars MAR 2023 (Values in Cr)
Net Income 3.44
Cash from Operations 3.28
Cash from Investing -5.08
Cash from Financing -8.17
Net change in Cash -9.97
Free Cash Flow 7.35
Particulars MAR 2022 (Values in Cr)
Net Income 3.87
Cash from Operations -6.59
Cash from Investing -5.34
Cash from Financing 9.79
Net change in Cash -2.14
Free Cash Flow -1.98
Particulars MAR 2021 (Values in Cr)
Net Income 10.50
Cash from Operations 12.81
Cash from Investing -3.50
Cash from Financing -0.45
Net change in Cash 8.85
Free Cash Flow 13.19
Particulars MAR 2020 (Values in Cr)
Net Income 5.64
Cash from Operations 9.30
Cash from Investing -2.20
Cash from Financing -5.51
Net change in Cash 1.57
Free Cash Flow 9.97
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 60.41 39.23 3.37 462.94 35.27 / 77.70
BLISS GVS PHARMA LTD 127.90 13.17 1.39 1346.81 77.65 / 148.95
CIPLA LTD 1595.25 28.98 4.82 128827.12 1132.00 / 1702.00
FERMENTA BIOTECH LIMITED 313.60 0.00 3.19 922.96 144.45 / 332.50
GLAXOSMITHKLINE PHARMA LT 2782.55 61.20 26.51 47138.08 1387.90 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 60.41 91.53 11.48 462.94 35.27 / 77.70
AMRUTAJAN HEALTH LTD 773.90 52.54 7.75 2237.39 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 7788.20 148.63 27.34 19470.50 4050.15 / 8139.85
BLISS GVS PHARMA LTD 127.90 13.80 1.36 1346.81 77.65 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 213.70
  • 26 Days 204.20
  • 10 Days 211.60
  • 50 Days 197.30
  • 12 Days 211.00
  • 100 Days 200.30
  • 20 Days 207.30
  • 200 Days 128.00
212.08
PIVOT
First Resistance 221.27
Second Resistance 227.68
Third Resistance 236.87
First Support 205.67
Second Support 196.48
Third Support 190.07
RSI 65.24
MACD 6.71
Commodity Channel Index (CCI) 46.78
ADX 41.34
Williams % R -44.27

Over 1 Month

down

12.78

Over 3 Months

down

15.26

Over 6 Months

down

14.46

Over 1 Year

down

79.41

Over 3 Years

down

13.33

Over 5 Years

down

32.30

AURO LABORATORIES LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

AURO LABORATORIES LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
47.84
Promoter Holdings
52.15
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Auro Impex Private Ltd Shareholding of Promoter and Promoter Group 1168781.0 18.75
Sharat Deorah Shareholding of Promoter and Promoter Group 1165800.0 18.71
Siddhartha Deorah Shareholding of Promoter and Promoter Group 441650.0 7.09
Samridhi Deorah Shareholding of Promoter and Promoter Group 241191.0 3.87
Sharat Deorah Huf Shareholding of Promoter and Promoter Group 229029.0 3.67
Kirtilaben Jayantilal Mehta Public Shareholding 195000.0 3.13
Shikha Lohia Public Shareholding 96126.0 1.54
Siddhartha Deorah Huf Shareholding of Promoter and Promoter Group 3859.0 0.06

AURO LABORATORIES LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About AURO LABORATORIES LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by AURO LABORATORIES LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Auro Laboratories Ltd?

Answer Field

The share price of Auro Laboratories Ltd for NSE is ₹ 0.00 and for BSE is ₹ 219.65.

What is the Market Cap of Auro Laboratories Ltd?

Answer Field

The market cap of Auro Laboratories Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 1,36.80 Cr. as of now.

What is the 52 Week High and Low of Auro Laboratories Ltd?

Answer Field

The 52 Week High and Low of Auro Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 307.20 and ₹ 105.20.

How to Buy Auro Laboratories Ltd share?

Answer Field

You can trade in Auro Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Auro Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 79.41%.

What is the Current Share Price of Auro Laboratories Ltd?

Answer Field

Auro Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 219.65 as on Oct 14 2024 03:29 PM.

What is the Market Cap of Auro Laboratories Ltd Share?

Answer Field

The market cap of Auro Laboratories Ltd for NSE ₹ 0.0 & for BSE ₹ 1,36.80 as on Oct 14 2024 03:29 PM.

What is the P/E Ratio of Auro Laboratories Ltd Share?

Answer Field

As on Oct 14 2024 03:29 PM the price-to-earnings (PE) ratio for Auro Laboratories Ltd share is 17.22.

What is the PB ratio of Auro Laboratories Ltd Share?

Answer Field

As on Oct 14 2024 03:29 PM, the price-to-book (PB) ratio for Auro Laboratories Ltd share is 67.34.

How to Buy Auro Laboratories Ltd Share?

Answer Field

You can trade in Auro Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Auro Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Auro Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Auro Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader